A blog bringing you perspectives from the frontlines of the drug pricing debate.

Pharmacy Benefit Managers Are Key to Helping Retirees

Published in Morning Consult  With the United States in a debate on high drug prices, solutions are being…

Health Care Purchasers Call on Congress to Take Action to Boost Competition

By Debra Barrett, Coalition for Affordable Prescription Drugs, James Gelfand, ERIC and Andrew MacPherson, Public Sector HealthCare Roundtable…

Creating a Competitive Marketplace that Works for Patients

U.S. patients, payors and the health care system are spending billions of dollars more on prescription drugs than…

Meaningful Transparency

As policymakers seek to address widespread concern about high drug prices, the conversation often includes a call for…

Creating a Marketplace that Works for Patients

The challenge of high and rising drug prices affects almost all Americans – and voters are unified in…

Real solutions to easing the burden of high drug costs

Read full op-ed in The Hill  The last few weeks have seen a flurry of activity with several…

Soaring Drug Prices: The Time to Act Is Now

As Congress continues to examine the issue of drug pricing, there is one thing we can all agree…

Retired Teachers on the Front Lines of the Drug Pricing Debate

By Jane Gilbert Published in Morning Consult More than two-thirds of Americans report that they are very concerned about the…

Big Pharma: New Year, New Price Hikes

There seems to be no shortage of breaking news as we kick off 2019, but top of mind…

Drug Pricing in 2018: The Top 10 Toughest Pills to Swallow

As 2018 comes to a close, we look back at a year filled with soaring drug prices and…